President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and ...

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

Dr. Oz has extolled Ozempic’s promise for weight-loss. Now Medicare, which Trump wants Oz to oversee, may cover it.

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

Weight loss drugs like Ozempic have become a popular option for helping people who struggle to lose weight, but they could ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.

With abuse of weight loss drugs continuing to be an issue in Australia, researchers from the University of South Australia ...

A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose weight. While these drugs are becoming wildly popular, they can cause ...

While Ozempic bodes well for weight loss, some users are concerned the drug's impact also means unwanted changes to their ...

The rise in obesity rates across the United States has brought increased attention to treatments aimed at addressing the ...